Sign in
4

Changes in Ownership

LB PHARMACEUTICALS INC Filed Acc 0001746372-26-000007

Options or other derivatives

  • Chief Financial Officer acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Miller Joseph M Chief Financial Officer 2026-10-09 Grant or award · Emplopyee Stock Option (Right to Buy) +200,000 200,000 D
Loading xslF345X06/form4-10132026_041004.xml…